Bruker Corp (BRKR)

Industry Medical Devices
This stock can be held in an Investment ISA and an Investment Account
Sell

$37.66

Buy

$37.70

arrow-down$-0.15 (-0.40%)

Bruker Corp is a developer, manufacturer and distributor of scientific instruments and analytical and dignostic solutions that enable customers to explore life and materials at microscopic, molecular and cellular levels.
Prices updated at 05 Jun 2025, 20:31 EDT
| Prices minimum 15 mins delay
|
Prices in USD
NASDAQ
arrow-down-0.73%
NASDAQ
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Medical Devices
Chairman
Dr. Frank H. Laukien,PhD
CEO
Dr. Frank H. Laukien,PhD
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
11,396
Head office
40 Manning Road
Billerica
United States
01821
mobile
+1 978 663-3660
letter
investor.relations@bruker.com
computer
Company website

Key personnel

Owner nameSalaryBonusAll other compensationTotal compensationRestricted stock award
Ms. Laura A. Francis
Independent Director
-----
Mr. Thomas Bures
Chief Accounting Officer
-----
Dr. Frank H. Laukien,PhD
Chairman of the Board, President and Chief Executive Officer
0.97m--5.53m-
Mr. John A. Ornell
Independent Director
0.11m--0.27m-
Dr. Mark R. Munch,PhD
Executive Vice President; President of Bruker Nano Group and Bruker Nano Surfaces Division
0.73m0.30m-2.64m-
Mr. Richard A. Packer
Independent Director
0.09m--0.26m-
Dr. William A. Linton
Lead Independent Director
0.10m--0.27m-
Ms. Adelene Q. Perkins
Independent Director
0.09m--0.26m-
Mr. Gerald N. Herman
Executive Vice President and Chief Financial Officer
0.64m--2.29m-
Dr. Hermann Requardt
Independent Director
0.09m--0.25m-
Dr. Robert J. Rosenthal, PhD
Independent Director
0.09m--0.26m-
Mr. Burkhard Prause
President and Chief Executive Officer, Bruker Energy & Supercon Technologies, Inc
-----
Mr. Juergen Srega
President, Bruker CALID Group and Bruker Daltonics Division
0.48m0.00m-1.52m-
Ms. Bonnie H. Anderson
Independent Director
0.09m--0.26m-
Dr. Cynthia M. Friend, PhD
Independent Director
0.09m--0.25m-
Mr. Falko Busse
President, Bruker BioSpin Group
0.50m--1.47m-

Top 5 shareholders

Owner nameNo. of sharesShare as % of port.Last changePortfolio % changeDate of portfolio% Total assets
FMR LLC14,242,121-480983250.99326431 May 20259.39
T. Rowe Price Investment Management,Inc.12,383,3500.34193-11640-0.09390931 May 20258.17
BlackRock Inc11,399,7940.009995960425.51699131 May 20257.52
FMR Inc10,628,0990.02832-3221499-23.26059631 May 20257.01
Fidelity Management and Research Company10,628,0990.02832-3221499-23.26059631 May 20257.01

Director dealings

DateActionNamePriceValueNo. of sharesHolding (%)Additional info
02 Dec 2024-Mr. Richard A. Packer-----
02 Dec 2024-Mr. Richard A. Packer57.82193,68380,904--
02 Dec 2024-Mr. Richard A. Packer19.12191,20084,254--
22 Nov 2024-Dr. William A. Linton-----
22 Nov 2024-Dr. William A. Linton19.12191,20045,425--
18 Nov 2024-Dr. Frank H. Laukien,PhD51.36184,02338,439,563--
18 Nov 2024-Dr. Frank H. Laukien,PhD49.823,480,72438,409,429--
18 Nov 2024-Dr. Frank H. Laukien,PhD50.821,349,32238,435,980--
15 Aug 2024-Rosenthal Bob24.00240,00035,647--
15 Aug 2024-Rosenthal Bob-----
15 Aug 2024-Rosenthal Bob-----
15 Aug 2024-Rosenthal Bob63.14295,74830,963--
15 Aug 2024-Rosenthal Bob20.8352,07525,647--
09 Aug 2024-Dr. Frank H. Laukien,PhD--2,543--
11 Aug 2024-Dr. Frank H. Laukien,PhD60.42292,31238,339,563--
10 Aug 2024-Dr. Frank H. Laukien,PhD60.42281,37638,344,401--
09 Aug 2024-Dr. Frank H. Laukien,PhD--38,349,058--
09 Aug 2024-Mr. Gerald N. Herman--84,500--
09 Aug 2024-Mr. Gerald N. Herman--13,742--
11 Aug 2024-Mr. Gerald N. Herman60.4264,46881,962--
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.